Biography
John F. Kokai-Kun, PhD is Vice President of Non-clinical Affairs for Synthetic Biologics, Inc. (Rockville, MD). He received his BS in Biochemistry from Juniata College in Huntingdon, PA and his PhD in Microbiology from the University of Pittsburgh, School of Medicine. He served as a post-doctoral researcher at the Uniformed Services University of the Health Sciences in Bethesda, MD. Dr. Kokai-Kun has 20 years of experience in the drug development industry and has held positions with several biotechnology and pharmaceutical companies where his research and development efforts have focused primarily on anti-bacterial drugs and vaccines. He is also an Adjunct Assistant Professor of Microbiology and Immunology at the Uniformed Services University and retired from the United States Army.
Research Interest
Anti-bacterial drugs and vaccines
Biography
Deb Mathews received her doctorate of Pharmacy degree from Florida A&M University and has over 25 years of clinical and pharmaceutical executive experience. She spent her early years in clinical practice as research pharmacist in Oncology with the University of Miami Hospital and Head of Pharmacy Services / Adherence Manager for the HIV/AIDS program with Jackson Memorial Hospital in Miami. She has worked in several leadership positions with the pharmaceutical industry focused on Medical Affairs, scientific insights, publications and data dissemination. She currently serves as Vice-President Medical Affairs for Synthetic Biologics, Inc. She is interested in mechanistic methodologies for personalized medicine in antimicrobial resistance and biomarker identification linked to clinical outcomes
Research Interest
Mechanistic methodologies for personalized medicine in antimicrobial resistance and biomarker identification linked to clinical outcomes.
Biography
John J.S. Cadwell received his degree in pharmacology from the University of Miami in 1981. He spent additional time studying at the University of Nottingham and the National Institute of Medical Research at Mill Hill, outside of London. He served in various capacities in the biomedical research fields until 2000 when he was founder of FiberCell Systems Inc. a company specializing in the research and supply of hollow fiber bioreactors. He has over 10 publications in the field and three patents relating to hollow fiber systems and is considered a world expert in the field.
Research Interest
Cell culture technology, stem cells, numismatics, oenophilia, cerevisaphilia, rock art posters, gratefuldeadophilia.